Erratum to: ‘Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance’ (J Hepatol 2019; 71(1): 14-24) (Journal of Hepatology (2019) 71(1) (14–24), (S016882781930128X), (10.1016/j.jhep.2019.02.013))

Sabrina J. Merat, Camille Bru, Dorien van de Berg, Richard Molenkamp, Alexander W. Tarr, Sylvie Koekkoek, Neeltje A. Kootstra, Maria Prins, Jonathan K. Ball, Arjen Q. Bakker, Menno D. de Jong, Hergen Spits, Tim Beaumont, Janke Schinkel

Research output: Contribution to journalComment/Letter to the editorAcademic

Abstract

It has come to our attention that there is an error in Fig. 2A and consequently the Graphical Abstract of our manuscript. During the production process, the colors used in the legend to the pie chart were incorrectly assigned, so that those representing AR3 and AR4 were reversed. Please see the corrected Fig. 2 and Graphical Abstract below. We apologize for any inconvenience caused. [Figure presented] [Figure presented]
Original languageEnglish
Pages (from-to)999-1000
Number of pages2
JournalJournal of Hepatology
Volume73
Issue number4
Early online date2020
DOIs
Publication statusPublished - Oct 2020

Cite this